Centrifugation

Babson Diagnostics to Launch Transformative Blood Testing Service with Leading Retail Partners

Retrieved on: 
Thursday, March 21, 2024
Supermarket, Health Technology, Pharmaceutical, Oncology, Teens, Medical Devices, Parenting, Infectious Diseases, Retail, Genetics, Fitness & Nutrition, Cardiology, Health, Seniors, Practice Management, Men, General Health, Family, Consumer, Diabetes, Other Retail, Other Health, Biometrics, Diagnosis, Temperature, Patient, Pharmacy, Pharmacist, Prescription, Babson, Insurance, Centrifugation, Texas Pharmacy Association, Collection, Blood, FDA

Babson Diagnostics, a science-first health technology company, announced today that it will launch BetterWay™ blood testing with three retail partners in Austin and San Antonio.

Key Points: 
  • Babson Diagnostics, a science-first health technology company, announced today that it will launch BetterWay™ blood testing with three retail partners in Austin and San Antonio.
  • BetterWay brings blood testing into the 21st century, making it less invasive, more convenient, and accessible for consumers.
  • “Blood testing hasn’t changed much in over 70 years,” said David Stein, Babson’s chief executive officer.
  • Without the need for a phlebotomist, Babson can bring medically accurate blood testing to new, more convenient settings such as community pharmacies.

Waters Streamlines and Expedites PFAS Testing with Innovative Oasis Dual-Phase Cartridges

Retrieved on: 
Thursday, March 14, 2024
QC, Comment, GCB, PFAS, Phosphatidylethanolamine, Environment, WAT, Filtration, Risk, European Chemicals Agency, WAX, Carbon, Centrifugation, Workflow, Laboratory, EPA, Waters Corporation, Compensation, Safe Drinking Water Act, Biosolids, Soil, CERCLA, Extraction (chemistry), Cosmetics

MILFORD, Mass., March 14, 2024 /PRNewswire/ -- Waters Corporation (NYSE:WAT) announces new Oasis WAX/GCB and GCB/WAX for PFAS Analysis Cartridges with new design features that significantly streamline and expedite sample preparation and analysis of per- and polyfluoroalkyl substances (PFAS). To help ensure accuracy and further confidence in test results, Oasis WAX/GCB and GCB/WAX Cartridges are QC-tested by an accredited laboratory for low residual PFAS, to reduce or eliminate any time spent troubleshooting potential assay contamination.

Key Points: 
  • Waters Oasis™ Dual-phase PFAS Analysis Cartridges simplify sample preparation for EPA 1633 testing for analysis of PFAS concentrations in non-potable water, soils, biosolids, and tissue.
  • MILFORD, Mass., March 14, 2024 /PRNewswire/ -- Waters Corporation (NYSE:WAT) announces new Oasis WAX/GCB and GCB/WAX for PFAS Analysis Cartridges with new design features that significantly streamline and expedite sample preparation and analysis of per- and polyfluoroalkyl substances (PFAS).
  • Oasis WAX/GCB & GCB/WAX Cartridges are the latest products within Waters extensive portfolio of PFAS testing solutions.
  • Oasis WAX/GCB and GCB/WAX Cartridges are the latest products within a comprehensive portfolio of PFAS Testing Solutions offered by Waters to support the surging demand for PFAS environmental testing.

Waters Streamlines and Expedites PFAS Testing with Innovative Oasis Dual-Phase Cartridges

Retrieved on: 
Thursday, March 14, 2024
QC, Comment, GCB, PFAS, Phosphatidylethanolamine, Environment, WAT, Filtration, Risk, European Chemicals Agency, WAX, Carbon, Centrifugation, Workflow, Laboratory, EPA, Waters Corporation, Compensation, Safe Drinking Water Act, Biosolids, Soil, CERCLA, Extraction (chemistry), Cosmetics

MILFORD, Mass., March 14, 2024 /PRNewswire/ -- Waters Corporation (NYSE:WAT) announces new Oasis WAX/GCB and GCB/WAX for PFAS Analysis Cartridges with new design features that significantly streamline and expedite sample preparation and analysis of per- and polyfluoroalkyl substances (PFAS). To help ensure accuracy and further confidence in test results, Oasis WAX/GCB and GCB/WAX Cartridges are QC-tested by an accredited laboratory for low residual PFAS, to reduce or eliminate any time spent troubleshooting potential assay contamination.

Key Points: 
  • Waters Oasis™ Dual-phase PFAS Analysis Cartridges simplify sample preparation for EPA 1633 testing for analysis of PFAS concentrations in non-potable water, soils, biosolids, and tissue.
  • Cartridge lots are QC-tested by an accredited laboratory for low residual PFAS to help reduce or eliminate time spent troubleshooting PFAS contamination.
  • MILFORD, Mass., March 14, 2024 /PRNewswire/ -- Waters Corporation (NYSE:WAT) announces new Oasis WAX/GCB and GCB/WAX for PFAS Analysis Cartridges with new design features that significantly streamline and expedite sample preparation and analysis of per- and polyfluoroalkyl substances (PFAS).
  • Oasis WAX/GCB and GCB/WAX Cartridges are the latest products within a comprehensive portfolio of PFAS Testing Solutions offered by Waters to support the surging demand for PFAS environmental testing.

Kyverna Therapeutics announces first publication of Ingenui-T, a novel CAR T-cell vein-to-vein manufacturing process

Retrieved on: 
Wednesday, January 24, 2024
Bed, Patient, Therapy, Leukapheresis, Collection, Centrifugation, Ingenui, CD19, Caregiver, BioRxiv

EMERYVILLE, Calif., Jan. 24, 2024 /PRNewswire/ -- Kyverna Therapeutics, Inc. (Kyverna), a patient-centered clinical-stage biopharmaceutical company focused on developing cell therapies for patients suffering from autoimmune diseases, today announced the publication in BioRxiv of a paper describing Kyverna's proprietary manufacturing process that utilizes less than 300 ml of whole blood from a blood draw instead of apheresis for the collection of T cells from patients undergoing chimeric antigen receptor (CAR) T-cell therapy.

Key Points: 
  • Leukapheresis - a specific type of apheresis - is a conventional starting material for CAR T-cell therapy.
  • The procedure poses challenges due to its length and invasiveness, cost, limited capacity of apheresis beds, and resource constraints at the collection center.
  • "We were able to achieve a process minimization without compromising the quality of the operations or the characteristics of the resulting product."
  • CAR T-cell therapy involves modifying a patient's T cells to recognize and remove B cells in the patient's body.

Babson Diagnostics’ BetterWay™ Blood Testing Service Achieves Critical Milestone Ahead of Commercialization

Retrieved on: 
Thursday, December 7, 2023
Biotechnology, Technology, FDA, Other Health, Health, General Health, Health Technology, Other Science, Other Technology, Medical Devices, Science, IRB, Food, CPT, Multimedia, Blood, Ecosystem, Centrifugation, Partnership, Pharmacy, Medical device, Hospital, Babson

View the full release here: https://www.businesswire.com/news/home/20231207903396/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20231207903396/en/
    BetterWay™ Blood Testing, the name of its new diagnostic blood testing service that is designed around the most important element of testing – the customer.
  • (Graphic: Business Wire)
    BetterWay will reimagine the entire blood testing process, using only a pea-sized amount of blood collected from a fingertip and delivering results equivalent to traditional blood testing methods.
  • The BetterWay service will enable blood testing by non-phlebotomists in convenient locations without sacrificing quality, accuracy, or the types of tests that are possible.
  • “BetterWay is the blood testing service that consumers and health care professionals have been waiting for,” said David Stein, chief executive officer of Babson Diagnostics.

Global Peripheral Blood Mononuclear Cells Research Report 2023: Industry Size, Share, Trends, Opportunities, and Forecasts, 2018-2028 - ResearchAndMarkets.com

Retrieved on: 
Tuesday, October 10, 2023
Research, Science, Transfer, ACT, National library, Infection, Application, Splenic infarction, Poisoning, Drug development, Stroke, Plasma, Biology, Prevalence, Regenerative medicine, Cell, USD, Trypanosoma cruzi, Safety, Wound healing, Toxicity, Transplant, R, Cancer, PBMC, Growth, Centrifugation, Protein, Immune system, HPV, Pathology, Drug discovery, Toxicology, NK, Korea Disease Control and Prevention Agency, Competition, Heart, United States National Library of Medicine, Pharmaceutical industry, Vaccine

The growth of the peripheral blood mononuclear cells (PBMC) industry is fueled by increasing customer awareness and a rising preference for antibody development.

Key Points: 
  • The growth of the peripheral blood mononuclear cells (PBMC) industry is fueled by increasing customer awareness and a rising preference for antibody development.
  • As demand for PBMCs in immunotoxicity research grows, the global peripheral blood mononuclear cells market continues to expand.
  • This growing awareness and collaborative R&D efforts positively impact the global peripheral blood mononuclear cells market's growth.
  • Company Profiles: Detailed analysis of the major companies present in global peripheral blood mononuclear cells market.

Single-Use Filtration Assemblies Gain Momentum in Biopharmaceuticals and Lab Applications, Fueling Market Growth - ResearchAndMarkets.com

Retrieved on: 
Thursday, September 21, 2023
Biotechnology, Medical Devices, Manufacturing, Other Manufacturing, Health, Centrifugation, Diabetes, TFF, Ageing, Cancer, Research, Compound annual growth rate, Membrane, Laboratory, Application, Conditional sentence, Growth, Syringe, Sewage treatment, Fine chemical

The global single-use filtration assemblies market is poised for substantial growth, with an expected value of $8.1 billion by 2028, marked by a remarkable Compound Annual Growth Rate (CAGR) of 17.8% during the forecast period.

Key Points: 
  • The global single-use filtration assemblies market is poised for substantial growth, with an expected value of $8.1 billion by 2028, marked by a remarkable Compound Annual Growth Rate (CAGR) of 17.8% during the forecast period.
  • Single-use filtration assemblies are vital components linking equipment and instruments in laboratories and the medical field.
  • These assemblies are categorized into filtration assemblies, bottle assemblies, bag assemblies, and mixing system assemblies.
  • Leachables and Extractables Concerns: One of the main challenges in the single-use filtration assemblies market is addressing lower detection limits for leachables and extractables.

AXIM® Biotechnologies Develops First Non-Invasive, Rapid, Point-of-Care, Diagnostic Test for Parkinson’s Disease

Retrieved on: 
Tuesday, September 12, 2023
Science, Neurology, Biotechnology, Research, Pharmaceutical, General Health, Health, Genetics, Alpha-synuclein, PD, Centrifugation, Celsius, Neurodegenerative disease, The Michael J. Fox Foundation, Tears, II, Organization, Bicinchoninic acid assay, Parkinson's disease, Synuclein, Patient, Freezing, Lactoferrin, Diagnosis, III, Alzheimer's disease, Medical imaging, Palladium

Fox Foundation shows that the presence of abnormal alpha-synuclein was detected in an astonishing 93% of people with Parkinson’s who participated in the study.

Key Points: 
  • Fox Foundation shows that the presence of abnormal alpha-synuclein was detected in an astonishing 93% of people with Parkinson’s who participated in the study.
  • These findings suggest a crucial role for α-synuclein in therapeutic development, both in identifying pathologically defined subgroups of people with Parkinson's disease and establishing biomarker-defined at-risk cohorts.
  • Total tear protein content is first quantified using a bicinchoninic acid assay followed by alpha-Synuclein using a bulky plate reader.
  • AXIM is already marketing a lactoferrin assay, which may be used in conjunction with the newly developed novel Synuclein test.

Boekel Scientific Introduces New Centrifuge Product Line

Retrieved on: 
Monday, August 21, 2023
Centrifugation, Catalog, Blood bank, Research, Multimedia, STAT, LED, Steam, Laboratory, Water, Physics, VDC, Longevity, Compressed air

FEASTERVILLE-TREVOSE, Pa., Aug. 21, 2023 /PRNewswire/ -- Boekel Scientific introduces a new product line that consists of 4 families of centrifuges : economy, general purpose, STAT, and Blood Bank .

Key Points: 
  • FEASTERVILLE-TREVOSE, Pa., Aug. 21, 2023 /PRNewswire/ -- Boekel Scientific introduces a new product line that consists of 4 families of centrifuges : economy, general purpose, STAT, and Blood Bank .
  • Boekel Scientific, renowned for its storied history within the labware and laboratory apparatus manufacturing field, is well versed in centrifugation.
  • This new line of centrifuges combine modern technologies such as LED light indicators and brushless motors with the trusted Boekel Scientific quality and durability known for generations.
  • The Boekel Scientific centrifuges are all proudly made in the USA, with design, manufacturing, and product support residing in Pennsylvania.

MANA Develops Novel "Drycell" Microdroplets to Make Handling Single Cell Easier

Retrieved on: 
Thursday, August 3, 2023
Nanoparticle, Research institute, Single-cell analysis, MANA, Centrifugation, Micrometer, Nanotechnology, Cell, Vaccine

To analyze individual cells, the desired number of cells must be isolated spatially. This often requires extensive training and use of expensive laboratory equipment. MANA scientists have recently overcome this hurdle using nanotechnology. They coated cell-suspension microdroplets with superhydrophobic nanoparticles -- tiny particles that possess surfaces with exceptional water-repellent properties -- and created spherical structures known as "drycells," with customizable sizes ranging from one to several hundred micrometers, which can be handled and picked up with ease. This will make cell picking easier and greatly facilitate single-cell analysis.

Key Points: 
  • This often requires extensive training and use of expensive laboratory equipment.
  • MANA scientists have recently overcome this hurdle using nanotechnology.
  • This will make cell picking easier and greatly facilitate single-cell analysis.
  • They were also able to simultaneously encapsulate normal and cancerous cells as well as creating several cell colonies inside these drycells.